Economist Alex Brill mentioned in his testimony that "a properly designed pathway for biogeneric entry will, over time, lead to additional market entrants, lower prices, increased access to drugs and a few billion dollars a year in reduced spending."
Take a look at the full post at Patent Docs to see the rest of Mr. Brill's testimony.
If you'r

Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment